Skip to main content
Premium Trial:

Request an Annual Quote

Peakadilly Wins $2.2M from Flanders Government to Develop Protein Biomarker Platform


NEW YORK (GenomeWeb News) – The Flanders government has extended a grant to Peakadilly to speed up development of its biomarker discovery platform, the Belgian company said today.
 
The company plans to use the funds, which total €1.7 million ($2.2 million), to expand relationships with pharma and diagnostic companies and to accelerate development of its own diagnostic products.
 
Peakadilly's biomarker discovery platform is based on its MASStermind techonology, which includes mass spectrometry techniques and data interpretation methods.
 
The Institute for the Promotion of Innovation by Science and Technology in Flanders made the grant extension.
 
In August, Peakadilly raised $10.9 million in venture capital funding.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more